Your browser doesn't support javascript.
loading
Epigenetic modulators provide a path to understanding disease and therapeutic opportunity.
Honer, Madison A; Ferman, Benjamin I; Gray, Zach H; Bondarenko, Elena A; Whetstine, Johnathan R.
Affiliation
  • Honer MA; Cancer Epigenetics Institute, Fox Chase Cancer Center, Philadelphia, Pennsylvania 19111, USA.
  • Ferman BI; Nuclear Dynamics and Cancer Program, Fox Chase Cancer Center, Philadelphia, Pennsylvania 19111, USA.
  • Gray ZH; Institute for Cancer Research, Fox Chase Cancer Center, Philadelphia, Pennsylvania 19111, USA.
  • Bondarenko EA; Biomedical Sciences Program, Lewis Katz School of Medicine, Temple University, Philadelphia, Pennsylvania 19140, USA.
  • Whetstine JR; Cancer Epigenetics Institute, Fox Chase Cancer Center, Philadelphia, Pennsylvania 19111, USA.
Genes Dev ; 38(11-12): 473-503, 2024 Jul 19.
Article in En | MEDLINE | ID: mdl-38914477
ABSTRACT
The discovery of epigenetic modulators (writers, erasers, readers, and remodelers) has shed light on previously underappreciated biological mechanisms that promote diseases. With these insights, novel biomarkers and innovative combination therapies can be used to address challenging and difficult to treat disease states. This review highlights key mechanisms that epigenetic writers, erasers, readers, and remodelers control, as well as their connection with disease states and recent advances in associated epigenetic therapies.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Epigenesis, Genetic Limits: Animals / Humans Language: En Journal: Genes Dev Year: 2024 Document type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Epigenesis, Genetic Limits: Animals / Humans Language: En Journal: Genes Dev Year: 2024 Document type: Article